Testing effectiveness (Phase 2)Study completedNCT00933361
What this trial is testing
Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study
Who this might be right for
Advanced CancerCachexia
Cantonal Hospital of St. Gallen 21